Related Experiment Video

Updated: Jun 24, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Chlamydia pneumoniae-induced pathological signaling in the vasculature

Jan Marco Kern1, Viola Maass, Matthias Maass

  • 1Institute for Medical Microbiology, Hygiene and Infectious Diseases, Paracelsus Medical Private University, University Hospital Salzburg, Austria.

FEMS Immunology and Medical Microbiology
|March 14, 2009
PubMed

Insights

Chlamydia pneumoniae, a persistent intracellular bacterium, is linked to atherosclerosis. Understanding its role in vascular disease is crucial as current antibiotics fail to eradicate it from plaques.

Area of Science:

  • Microbiology
  • Pathogen Biology
  • Vascular Disease Research

Background:

  • Chlamydia pneumoniae is an enigmatic intracellular bacterium, highly prevalent but difficult to culture.
  • It is associated with chronic diseases, particularly atherosclerosis, residing within arterial plaques.
  • Persistent C. pneumoniae in plaques is resistant to current antibiotic therapies, necessitating a deeper understanding of its pathobiology.

Purpose of the Study:

  • To review the proproliferative and proinflammatory effects of vascular Chlamydia pneumoniae infection.
  • To explore the potential link between C. pneumoniae infection and atherogenesis.
  • To highlight the need for better understanding of chlamydial persistence in vascular disease.

Main Methods:

  • Review of existing literature on Chlamydia pneumoniae and atherosclerosis.
  • Analysis of in vitro and in vivo studies concerning vascular infection.
  • Synthesis of knowledge on host cell signaling pathways affected by C. pneumoniae.

Main Results:

  • Chlamydia pneumoniae induces angiogenesis and inflammation in vitro, key events in atherosclerosis.
  • The bacterium can exist in proliferative and nonreplicative states, contributing to persistence.
  • In vivo evidence for C. pneumoniae's contribution to atherosclerosis progression remains inconclusive.

Conclusions:

  • Vascular Chlamydia pneumoniae infection exhibits proproliferative and proinflammatory effects.
  • Understanding chlamydial persistence is essential for developing effective treatments for atherosclerosis.
  • Further in vivo research is needed to confirm the role of C. pneumoniae in atherosclerosis progression.

More Related Videos

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...